Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC on the link between acute MI and sleep duration. This study appears to show similar results as regards sleep duration and stroke. 

Cantidad de horas de sueño y riesgo de stroke

The work prospectively included 79,881 men and women between 45 and 79 followed up until their first event (event or stroke) for mean 14.6 years. The study also looked into genetic polymorphisms identified with sleep duration obtained from a publicly available database (MEGASTROKE and the International Stroke Genetics Consortia).

Long sleep (>9 hours a day) was associated with increased total risk of stroke and ischemic stroke (HR 1.12 and 1.14, respectively), while short sleep (<7 hours a day) increased the risk of intracranial bleeding. 

These results replicate almost exactly the MI results, where sleeping over 9 hours a day or fewer than 6 hours a day increases MI risk by 20 to 30%.


Read also: Hours of Sleep and Myocardial Infarction Risk.


The genetic analysis was not that clear, opening the possibility of a casual association. Without question, we do not have enough information to recommend a number of hours of sleep a day as primary prevention strategy against MI or stroke.

Conclusion

This large prospective study associated long sleep with increased risk of total and ischemic stroke, while short sleep was associated to intracranial bleeding. 

Original Title: Sleep Duration and Stroke. Prospective Cohort Study and Mendelian Randomization Analysis.

Reference: Olga E. Titova et al. Stroke. 2020 Nov;51(11):3279-3285. doi: 10.1161/STROKEAHA.120.029902.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...